2021
DOI: 10.1039/d1nr02581c
|View full text |Cite
|
Sign up to set email alerts
|

Design of metal–organic framework composites in anti-cancer therapies

Abstract: Metal-organic frameworks are a class of new and promising anti-cancer materials. MOFs with adjustable pore size, large specific surface area, diverse structure, and excellent chemical and physical properties make them...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(14 citation statements)
references
References 120 publications
0
14
0
Order By: Relevance
“…MOFs were combined with inorganic materials to enhance their unique properties. Nevertheless, it is important to look into the specifics of their relationship [10]. Inorganic nanoparticles, which are frequently used, control the tumour's location's photothermal effect [10].…”
Section: Mofs As Biomarkersmentioning
confidence: 99%
See 1 more Smart Citation
“…MOFs were combined with inorganic materials to enhance their unique properties. Nevertheless, it is important to look into the specifics of their relationship [10]. Inorganic nanoparticles, which are frequently used, control the tumour's location's photothermal effect [10].…”
Section: Mofs As Biomarkersmentioning
confidence: 99%
“…Nevertheless, it is important to look into the specifics of their relationship [10]. Inorganic nanoparticles, which are frequently used, control the tumour's location's photothermal effect [10]. The colour of bimetallic ZIF nanoparticles darkens as the Co concentration rises.…”
Section: Mofs As Biomarkersmentioning
confidence: 99%
“…Since Horcajada et al tested MOFs as drug delivery systems (DDS) for the first time in 2008, there have been consistent efforts to improve their efficacy by devising strategies to avoid possible drug leakage (Horcajada et al, 2008;Pandey et al, 2020). Several MOFs have been developed in recent years as DDS for tumor therapy (Zheng et al, 2021). Nevertheless, the poor biocompatibility of MOFs is a major obstacle to their clinical translation (Chen et al, 2021).…”
Section: Introductionmentioning
confidence: 99%
“…Owing to the characteristic of abundant pore structures, multiple functional ligands and metalorganic frameworks (MOFs) attract growing attention as catalytic and drug carriers in nanomedicine applications. 20,21 The MOFs have been designed to conform to the requirements of high biosafety and the ability to carry drugs in vivo. 22 There were many pieces of research about stimuli-responsive MOFs nanoparticles, which were used for the controlled release of drugs and biomedical applications of therapeutics.…”
Section: Introductionmentioning
confidence: 99%